24
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Helicobacter pylori and Bleeding Duodenal Ulcer: Prevalence of the Infection and Role of Non-steroidal Anti-inflammatory Drugs

Pages 717-724 | Published online: 08 Jul 2009

References

  • Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717–27.
  • Mignon M, Penston JG, Deltenre M, Ruszniewski P, Dobrill G. Natural history of duodenal ulcer disease: are we at a turning point? Gastroenterol Int 1994;7:95–113.
  • Jaspersen D. Helicobacter pylori eradication: the best long-term prophylaxis for ulcer bleeding recurrence? Endoscopy 1995;27: 622–5.
  • Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9:59–69.
  • Gisbert JP, Blanco M, Mateos JM, Fernandez-Salazar L, Fernandez-Bermejo M, Cantero J, et al. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci 1999;44: 2295–302.
  • Vaira D, Menegatti M, Miglioli M. What is the role of Helicobacter pylori in complicated ulcer disease? Gastroenterology 1997;113:S78–84.
  • Sung JJ, Gisbert JP, Pajares JM. Helicobacter pylori and nonsteroidal anti-inflammatory drugs. The Year in Helicobacter pylori. Curr Opin Gastroenterol 2000;16 Suppl 1:539–43.
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.
  • Hosking SW, Ling TK, Yung MY, Cheng A, Chung SC, Leung JW, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ 1992;305:502–4.
  • Jensen DM, You S, Pelayo E, Jensen ME, and CURE Hemostasis Group. The prevalence of Helicobacter pylori and NSAID use in patients with severe UGI hemorrhage and their potential role in recurrence of ulcer bleeding [Abstract]. Gastroenterology 1992;100 Suppl:A90.
  • Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997;42:586–91.
  • Lee JM, Breslin NP, Fallon C, O’Morain CA. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. Am J Gastroenterol 2000;95:1166–70.
  • Gisbert JP, Boixeda D, Aller R, de la Serna C, Sanz E, Martin de Argila C, et al. Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of three triple therapies and the role of eradication in preventing a hemorrhagic recurrence [in Spanish]. Med Clin (Barc) 1999;112: 161–5.
  • Griñó P, Pascual S, Sáez J, Casellas JA, Quilez C, Belda G, et al. Infección por Helicobacter pylori en pacientes con hemorragia digestiva alta de origen péptico:comparación de métodos diagnósticos [Abstract]. Gastroenterol Hepatol 1999;22: 548.
  • al-Assi MT, Genta RM, Karttunen TJ, Graham DY. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. Endoscopy 1996;28: 229–33.
  • Malfertheiner P, Hackelsberger A, Dominguez-Muñoz JE, Illies G, Roessner A, Nilius M, et al. Is the H. pylori negative bleeding duodenal ulcer a myth? [Abstract]. Gastroenterology 1997;A481:1918.
  • Colin R, Czernichow P, Baty V, Touze I, Brazier F, Bretagne JF, et al. Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer. Gastroenterol Clin Biol 2000;24:31–5.
  • Archimandritis A, Tzivras M, Sougioultzis S, Papaparaskevas I, Apostolopoulos P, Avlami A, et al. Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non-variceal upper gastrointestinal bleeding. J Gastroenterol Hepatol 2000;15:369–73.
  • Romero Gomez M, Vargas J, Utrilla D, Rufo MC, Otero MA, Chavez M, et al. Prospective study on the influence of gastroduodenal ulcer hemorrhage on the diagnostic methods in Helicobacter pylori infection [in Spanish]. Gastroenterol Hepatol 1998;21:267–71.
  • Tu TC, Lee CL, Wu CH, Chen TK, Chan CC, Huang SH, et al. Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers. Gastrointest Endosc 1999;49:302–6.
  • Fantry GT, Rosenstein AH, James SP. Confounding factors in the detection of Helicobacter pylori infection in patients with upper gastrointestinal bleeding [Letter]. Am J Gastroenterol 1999;94:1421–2.
  • Leung WK, Sung JJ, Siu KL, Chan FK, Ling TK, Cheng AF. False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood. Am J Gastroenterol 1998;93:1914–8.
  • Lee JM, Breslin NP, Gopaul M, Koh CW, Kong TY, Soong MM, et al. The effects of blood on rapid urease testing for Helicobacter pylori in mucosal biopsies from the gastric antrum. Ir J Med Sci 2000;169:60–2.
  • Lai KC, Hui WM, Lam SK. Bleeding ulcers have high false negative rates for antral Helicobacter pylori when tested with urease test [Abstract]. Gastroenterology 1996;110:A167.
  • Archimandritis A, Tzivras M, Souyioulzis S, Papaparaskevas I, Apostolopoulos P, Delladetsima I, et al. High rates of false negative rapid urease test (CLO) in patients with upper gastrointestinal bleeding (UGB) [Abstract]. Gut 1997;41 Suppl 1):A76.
  • Taha AS, Boothman P, Nakshabendi I, Reid J, Morran C, Gemmell CG, et al. Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs. J Clin Pathol 1992;45:709–12.
  • Taha AS, Reid J, Boothmann P, Gemmell CG, Lee FD, Sturrock RD, et al. Serological diagnosis of Helicobacter pylori—evaluation of four tests in the presence or absence of nonsteroidal anti-inflammatory drugs. Gut 1993;34:461–5.
  • Lee CL, Tu TC, Yang RN, Lin HJ, Lin VL, Wu CH, et al. Does blood in the stomach influence the diagnosis of H. pylori infection in patients with bleeding peptic ulcer? [Abstract]. Gut 1997;41 Suppl 1):A76.
  • Hayat M, Duffet S, O’Mahony S, Moayyedi P, Dixon F, Axon AT, et al. Diagnosis of Helicobacter pylori infection in acute upper gastrointestinal haemorrhage; what is the best diagnostic test? [Abstract]. Gastroenterology 2000;118:A1245.
  • Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. Gut 1997;41 Suppl 2:S1–9.
  • Bianchi Porro G, Lazzaroni M. The conflicting relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding [Editorial]. Scand J Gastroenterol 1999;34:225–8.
  • Logan RP. Urea breath tests in the management of Helicobacter pylori infection. Gut 1998;43 Suppl 1:S47–50.
  • Labenz J, Peitz U, Kohl H, Kaiser J, Malfertheiner P, Hackelsberger A, et al. Helicobacter pylori increases the risk of peptic ulcer bleeding:a case-control study. Ital J Gastroenterol Hepatol 1999;31:110–5.
  • Kuyvenhoven JP, Veenendaal RA, Vandenbroucke JP. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system. Scand J Gastroenterol 1999;34: 1082–6.
  • Cullen DJ, Hawkey GM, Greenwood DC, Humphreys H, Shepherd V, Logan RF, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997;41:459–62.
  • Henriksson AE, Edman AC, Nilsson I, Bergqvist D, Wadstrom T. Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer. Scand J Gastroenterol 1998;33:1030–3.
  • Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case- control study. Gastroenterology 1999;116:1305–9.
  • Ng TM, Fock KM, Khor JL, eo EK, Sim CS, Tan AL, et al. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer. Aliment Pharmacol Ther 2000;14:203–9.
  • Hawkey CJ. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs. Gut 2000;46:310–1.
  • Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 1999;34:234–7.
  • Santolaria S, Lanas A, Benito R, Perez-Aisa M, Montoro M, Sainz R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment Pharmacol Ther 1999;13:1511–8.
  • Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995;41:5–7.
  • Sung JJ, Leung WK, Suen R, Leung VK, Chan FK, Ling TK, et al. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding. Dig Dis Sci 1997;42:2524–8.
  • Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995;41:1–4.
  • Schubert TT, Bologna SD, Nensey Y, Schubert AB, Mascha EJ, Ma CK. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age. Am J Med 1993;94:413–8.
  • Borody TJ, Brandi S, Andrews P, Jankiewicz E, Ostapowicz N. Helicobacter pylori–negative gastric ulcer. Am J Gastroenterol 1992;87:1403–6.
  • Soplepmann J, Peetsalu A, Peetsalu M, Tein A, Juhola M. Peptic ulcer haemorrhage in Tartu County, Estonia: epidemiology and mortality risk factors. Scand J Gastroenterol 1997;32:1195–200.
  • Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 1998;129:547–50.
  • Sainz R, Borda F, Dominguez E, Gisbert JP. Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group [in Spanish]. Rev Esp Enferm Dig 1999;91:777–84.
  • Sonnenberg A, Muller-Lissner SA, Vogel E, Schmid P, Gonvers JJ, Peter P, et al. Predictors of duodenal ulcer healing and relapse. Gastroenterology 1981;81:1061–7.
  • Gisbert JP, Pajares JM. Should H. pylori infection in duodenal ulcer be confirmed before administering eradicating treatment? [Editorial] [in Spanish]. Med Clin (Barc) 1999;113: 134–7.
  • McColl KE, el-Nujumi AM, Chittajallu RS, Dahill SW, Dorrian CA, el-Omar E, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993;34:762–8.
  • Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992;103:862–9.
  • Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615–25.
  • Marmo R, Rotondano G, Bianco MA, Cipolletta L. Helicobacter pylori and bleeding peptic ulcer: Do we really need a gold standard? Gastrointest Endosc 2000;52: 148.
  • Adamek RJ, Freitag M, Opferkuch W, Ruhl GH, Wegener M. Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study. Scand J Gastroenterol 1994;29:880–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.